Zhang Hanhong agreed to acquire 52.38% stake in Wuhan Huaye Pharmaceutical Co., Ltd. from Jianmin Pharmaceutical Group Co., Ltd. (SHSE:600976) for CNY 11 million on January 2, 2018. After completion of the transaction, Jianmin Pharmaceutical Group Co., Ltd. will hold no stake in Jianmin Pharmaceutical Group Co., Ltd. The Board of Directors of Jianmin Pharmaceutical Group Co., Ltd. approved the transaction on January 2, 2018. The transaction does not require shareholders’ approval. Zhang Hanhong cancelled the acquisition of 52.38% stake in Wuhan Huaye Pharmaceutical Co., Ltd. from Jianmin Pharmaceutical Group Co., Ltd. (SHSE:600976) on January 2, 2019.